Metraipolis › archive › dc_a612ce5ec090

Platelet-to-lymphocyte ratio for prognostication in immune checkpoint inhibitor-treated cancer patients: a meta-analysis of 13027 patients highlighting… — Europe PMC PMID:41705252

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41705252
DOI
10.3389/fimmu.2026.1732790
License (as archived)
solo-consultazione
Archived
2026-11-06T07:04:15.164Z
SHA-256 of the archived text
34729177e5c8d7a51a3272923eec4b1dd86fb9b9bce059b0fbea7acbcd3183fd
Stable URL of this page
https://metraipolis.com/documento/dc_a612ce5ec090

How to cite

Platelet-to-lymphocyte ratio for prognostication in immune checkpoint inhibitor-treated cancer patients: a meta-analysis of 13027 patients highlighting… — Europe PMC PMID:41705252 — Europe PMC (en), https://europepmc.org/article/MED/41705252 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a612ce5ec090 (Metraipolis archive dc_a612ce5ec090, sha256 34729177e5c8d7a51a3272923eec4b1dd86fb9b9bce059b0fbea7acbcd3183fd)
BibTeX
@misc{dca612ce5ec090,
  title = {Platelet-to-lymphocyte ratio for prognostication in immune checkpoint inhibitor-treated cancer patients: a meta-analysis of 13027 patients highlighting… — Europe PMC PMID:41705252},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41705252},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a612ce5ec090; sha256 34729177e5c8d7a51a3272923eec4b1dd86fb9b9bce059b0fbea7acbcd3183fd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41705252. Agents can read the archived copy with the MCP tool read_document.